Viewing StudyNCT00326339



Ignite Creation Date: 2024-05-05 @ 4:51 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00326339
Status: COMPLETED
Last Update Posted: 2009-04-20
First Post: 2006-05-12

Brief Title: Treatment of Arthritis With Syk Kinase Inhibition TASKI-1
Sponsor: Rigel Pharmaceuticals
Organization: Rigel Pharmaceuticals

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-08
Start Date Type: None
Primary Completion Date: 2007-10
Primary Completion Date Type: ACTUAL
Completion Date: 2007-12
Completion Date Type: ACTUAL
First Submit Date: 2006-05-12
First Submit QC Date: May 12 2006
Study First Post Date: 2006-05-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2009-04-16
Last Update Post Date: 2009-04-20
Last Update Post Date Type: ESTIMATED